Although no proven therapies exist, this JAMA article explores potential treatments for COVID-19 in repurposed drugs (chloroquine and hydroxychloroquine), lopinavir/ritonavir and other antiretrovirals, investigational drugs such as remdesivir, adjunctive therapies, and others.

This JAMA “Viewpoint” outlines the frameworks that should be used to inform decisions about how to modify cancer treatment based on patient and cancer-specific factors during these unprecedented COVID-19 times.

The University of Nebraska Medical Center’s innovative decontamination procedure involving the delivery of ultraviolet germicidal irradiation to used N95 masks has shown great promise in the fight against the shortage of PPEs.

A comprehensive guide from the American Medical Association (AMA), which includes information for those who want to support communities severely impacted by COVID-19, including the how and where to volunteer and all things to consider.

Data to support the use of hydroxychloroquine (HCQ) and chloroquine (CQ) for COVID-19 are limited and inconclusive; this article from the American College of Physicians (ACP) discusses the facts to arm yourself with the proper information.

The University of Nebraska Medical Center’s innovative decontamination procedure involving the delivery of ultraviolet germicidal irradiation to used N95 masks has shown great promise in the fight against the shortage of PPEs.